Studies from Johns Hopkins University Yield New Information about Stem Cell Research

2011 DEC 26 -- A report, "Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats," is newly published data in Neuroscience. According to the authors of a study from Madrid, Spain, "Hematic administration of bone marrow-derived mesenchymal stem cells (MSCs) in acute ischemic stroke may not only be an effective reparative treatment but also a brain protective therapy that improves neurological recovery. Our purpose was to study whether either i.v. or intracarotid (i.c.) administration of allogenic MSCs during the acute phase were effective in improving neurological recovery and decreasing brain damage in an...

Want to see the full article?

• Purchase this article for only $3.00